Tarsons Products Limited (NSE:TARSONS)
262.62
-4.70 (-1.76%)
Jun 19, 2026, 3:30 PM IST
Tarsons Products Market Cap
Tarsons Products has a market cap or net worth of 13.97 billion as of June 18, 2026. Its market cap has decreased by -30.26% in one year.
Market Cap
13.97B
Enterprise Value
17.65B
Revenue
4.23B
Ranking
n/a
PE Ratio
97.63
Stock Price
262.62
Market Cap Chart
Since November 26, 2021, Tarsons Products's market cap has decreased from 43.54B to 13.97B, a decrease of -67.91%. That is a compound annual growth rate of -22.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 13.97B | 12.57% |
| Dec 31, 2025 | 12.41B | -42.20% |
| Dec 31, 2024 | 21.48B | -24.21% |
| Dec 29, 2023 | 28.34B | -23.31% |
| Dec 30, 2022 | 36.95B | 7.67% |
| Dec 31, 2021 | 34.32B | -21.19% |
| Nov 26, 2021 | 43.54B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.38T |
| Divi's Laboratories | 1.80T |
| Apollo Hospitals Enterprise | 1.21T |
| Cipla | 1.09T |
| Krsnaa Diagnostics | 17.31B |
| Windlas Biotech | 16.86B |
| Ind-Swift Laboratories | 14.63B |
| Jagsonpal Pharmaceuticals | 14.14B |